Precision Telemed Champions Evidence-Based Wellness with Transparent GLP-1 and Hormone Therapies

The landscape of modern medicine is shifting. Treatments once reserved for bodybuilders or dismissed as fringe science are now making their way into mainstream clinical practice. At the forefront of this evolution is Precision Telemed, a Tampa-based telehealth company bridging the gap between pharmaceutical rigor and personal wellness.

Founded in 2024 by industry veteran and former Division I lacrosse athlete JP Rius, Precision Telemed is guided by a philosophy rooted in prevention, performance, and transparency. Drawing from over a decade in the pharmaceutical sector, Rius recognized that many therapies, like Testosterone therapy (TRT), Sermorelin peptide treatments, and NAD+ supplementation, showed clinical promise for longevity, cognitive function, and recovery.

Research backs these approaches. For example, a 2018 study published in Frontiers in Endocrinology highlighted that testosterone therapy lowered inflammation markers in men initiating treatment with exogenous testosterone injections. Despite such findings, misinformation and stigma often prevent patients from exploring safe, supervised therapies.

Precision Telemed aims to change that. By offering GLP-1 weight loss injections, including Tirzepatide at $299/month and Semaglutide at $199/month for all doses. The company provides clear, affordable access to some of the most in-demand medical weight loss solutions. Treatments are manufactured in FDA-registered, cGMP facilities, ensuring pharmaceutical-grade safety and quality.

Beyond GLP-1 medications, Precision Telemed integrates peptide therapies like Sermorelin growth hormone support, along with TRT and NAD+ injections. Each program is paired with lifestyle support, free workouts, and nutrition planning, creating a holistic model that blends medical science with behavioral change.

Unlike competitors, Precision Telemed has eliminated common barriers such as enrollment fees, forced memberships, and autopay requirements. The company even offers a 30-day money-back guarantee, signaling confidence in its therapies and a patient-first mindset.

"We embrace medicine too late in life," says Rius. "If treatments exist that can help us prevent disease, improve quality of life, and optimize performance, we should be using them now, not waiting for decline to happen."

With additional product launches planned for 2026 and long-term aspirations for dedicated optimization facilities, Precision Telemed represents more than a telehealth company; it's part of a growing movement to normalize proactive, science-driven wellness.

For patients, non-collegiate or non-professional athletes, and everyday individuals alike, that means the opportunity to harness proven science, responsibly applied, for better living.

For more information, visit www.precisiontelemed.com or connect on Instagram, Facebook, and LinkedIn.